China Pharma Holdings Engages in Taiwan’s TCM Showcase at CPHI Frankfurt 2025

Taiwan Showcases Traditional Chinese Medicine at CPHI Frankfurt 2025

Taiwan's commitment to advancing Traditional Chinese Medicine (TCM) receives a significant boost as the Taiwan Pavilion concludes its exhibition at CPHI Frankfurt 2025, held from October 28 to 30. Organized by the Taiwan Institute for Economic Research and spearheaded by the Department of Chinese Medicine and Pharmacy of the Taiwanese Ministry of Health and Welfare, the pavilion garners international attention and facilitates crucial exchanges between Taiwanese TCM companies and healthcare professionals worldwide. This event marks a pivotal moment for Taiwan, as it represents the country's first national TCM pavilion, showcasing its growing research capabilities and dedication to modernizing TCM practices.

During the exhibition, notable figures such as Mr. Mei-Shun Lo, Director General of the Taipei Representative Office in Germany, and Bertram Roth, Vice President of FrankfurtRheinMain GmbH, express strong support for Taiwan’s evidence-based initiatives in TCM. Their engagement underlines the potential for future collaborations between Taiwan and European healthcare sectors, promoting a shared vision of integrating traditional practices with contemporary medical approaches. The pavilion attracts a diverse array of international visitors, including pharmaceutical professionals, traders, and research institutions, all eager to explore Taiwanese innovations in TCM and the benefits of these practices in modern healthcare.

The success of the Taiwan Pavilion at CPHI Frankfurt not only elevates Taiwan’s status in the global healthcare arena but also emphasizes the importance of TCM in contemporary health practices. By showcasing advancements in science-based traditional medicine, Taiwan positions itself as a leader in the field, reinforcing its commitment to making a positive impact on global health. The exhibition serves as a crucial platform for fostering collaborations that could enhance TCM's role in international healthcare, paving the way for future advancements and partnerships.

In addition to the pavilion's activities, the event highlights the increasing global interest in TCM, driven by a rising demand for alternative and complementary therapies. Taiwan's strategic emphasis on evidence-based medicine sets it apart, appealing to an audience eager for reliable and effective health solutions. The successful exhibition at CPHI Frankfurt positions Taiwan not only as a proponent of traditional practices but also as a key player in the evolution of healthcare on the international stage.

Overall, Taiwan’s participation in CPHI Frankfurt 2025 underscores its proactive approach to promoting TCM and exploring new avenues for collaboration, signaling a promising future for traditional medicine in the global health landscape.